LAFEROBION

LAFEROBION Nasal powder

Packaging Composition Age
Nasal powder of 100,000 IU in vials. 5 vials in a blister made of PVC film coated with aluminium foil. 2 blisters in a cardboard pack. 1 vial contains 100,000 IU of human recombinant interferon alfa-2b children from 1 year of age and adults

Indications:

  • Prevention and treatment of influenza, as well as other acute respiratory viral infections (ARVIs) and viral-bacterial infections in adults and children, including newborns


LAFEROBION Suppositories

  • in the complex therapy of acute respiratory viral infections (ARVIs)

LAFEROBION nasal drops

  • Prevention and treatment of acute respiratory viral infections (ARVI)
  • seasonal epidemics

LAFEROBION nasal spray

  • in patients with recurrent and long-lasting upper respiratory tract diseases;
  • seasonal epidemics

X
SELF-MEDICATION CAN BE HARMFUL TO YOUR HEALTH. BEFORE USING THE DRUG, READ THE INSTRUCTION AND CONSULT YOUR PHYSICIAN